Research indicating that the drug may target cancer stem cells, which are often resistant to standard treatments. Fenbendazole Exhibits Antitumor Activity Against Cervical Cancer .
The American Cancer Society and other health authorities emphasize that while laboratory studies exist, Fenbendazole is not FDA-approved for human use, and large-scale clinical trials are still needed to confirm its safety and efficacy in people.
A report detailing three cases of advanced cancer (breast, prostate, and melanoma) where patients achieved remission after adding Fenbendazole to their regimens. Fenbendazole as an Anticancer Agent? A Case Series . Fenbendazole.org intersect.rar
Source: Nature Scientific Reports / PubMed Central Date: August 9, 2018 Key Findings:
It may block glucose uptake in cancer cells by downregulating GLUT transporters , effectively "starving" the tumor. Research indicating that the drug may target cancer
However, the primary research paper often cited by that community regarding the drug's potential anti-cancer mechanisms is:
The drug interferes with tubulin polymerization, a process essential for cancer cell division. A report detailing three cases of advanced cancer
An overview of the pharmacokinetics and promising biological activities for cancer therapy in both humans and animals. Oral Fenbendazole for Cancer Therapy .